Clinical Trials Directory

Trials / Completed

CompletedNCT05892939

Effects of Intranasal Oxytocin on Fear Processing in Naturalistic Contexts

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The main aim of the study is to investigate the modulatory effects of intranasal oxytocin (24IU) on fear in naturalistic social and non-social contexts and the underlying neural mechanisms.

Detailed description

In a double-blind placebo-controlled between-subject experimental design, 60 adult male subjects will be randomly allocated to receive either intranasal oxytocin (24IU, n= 30) or placebo (n = 30) nasal spray. 45 minutes after treatment the participants will undergo a naturalistic fear induction paradigm during fMRI. During the paradigm video clips of 25s lengths will be presented showing fear-inducing situations in social and non-social contexts as well as corresponding control video clips. Following each clip subjects are required to rate their level of subjective fear on a rating scale ranging from 1 (no fear) to 9 (highest fear). Participants will undergo screening for psychopathological and emotional states before treatment. Together with a randomized assignment to the treatment groups, this will allow controlling for confounding between-group differences.

Conditions

Interventions

TypeNameDescription
DRUGintranasal Oxytocin(24IU)Administration of intranasal Oxytocin(24IU)
DRUGintranasal PlaceboAdministration of intranasal Placebo

Timeline

Start date
2023-05-23
Primary completion
2024-04-01
Completion
2024-04-15
First posted
2023-06-07
Last updated
2025-04-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05892939. Inclusion in this directory is not an endorsement.